z-logo
open-access-imgOpen Access
Teicoplanin-resistant coagulase-negative staphylococcal bacteraemia in patients with haematological malignancies: a problem of increasing importance
Author(s) -
Livio Pagano
Publication year - 1997
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/40.5.738
Subject(s) - teicoplanin , coagulase , medicine , bacteremia , vancomycin , staphylococcal infections , microbiology and biotechnology , intensive care medicine , staphylococcus , staphylococcus aureus , antibiotics , biology , bacteria , genetics
The antibiotics were subsequently given by the oral route (co-trimoxazole at the same dosage and ciprofloxacin at 250 mg tds) and, after 2 weeks, the dosages were reduced (co-trimoxazole 480 mg bd and ciprofloxacin 250 mg bd). The patient completed a 4 week course of this regimen, during which time she remained afebrile. She was discharged and, at a 6 month follow-up assessment, was well and exhibited no signs of relapse. This case demonstrates that co-trimoxazole in combination with ciprofloxacin may be effective therapy in patients with IE caused by high-level gentamicin-resistant enterococci.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom